Search
for
Sort by
Research 661–690 of 1000+
- Efficacy and safety of tofacitinib therapy in Asian patients with severe alopecia areata
- Psychosocial burden and the impact of illness perceptions and stigma on quality of life, anxiety and depression in alopecia areata: results from the Alopecia + Me study
- Immune therapies for alopecia areata: evidence and new perspectives
- Anxiety and Depression in Patients with Alopecia Areata in Eskisehir, Turkey
- A Threefold Association Between Vitiligo and Alopecia Areata: Results from a Nationwide Case-control Observational Study
- Taiwanese Dermatological Association consensus on the diagnosis and management of alopecia areata
- A Potential Role for IL-4 and IL-13 in an Alopecia Areata–Like Phenotype: A Clinical Perspective
- Evaluating dermatologists’ knowledge of and attitudes toward Janus kinase inhibitor therapy for the treatment of alopecia areata
- The Immunological Association between Alopecia Areata and Respiratory Diseases: A Systematic Review
- Cutaneous Mastocytosis Associated With Congenital Alopecia
- Comparative Study of Trichoscopic Features of Alopecia Areata between Adults and Children and between Different Body Parts (Scalp, Beard, Eyebrow, and Moustache)
- Trichoscopy pattern in alopecia areata: A systematic review and meta‐analysis
- Risk of autoimmune thyroid diseases in individuals with alopecia areata: A nationwide case‐control study
- Systemic Tofacitinib in Alopecia Areata: A Single Center Retrospective Descriptive Cohort Study
- The Burden of Disease in Alopecia Areata: Canadian Online Survey of Patients and Caregivers
- Assessing Alopecia Areata Management in Poland: Challenges in Medical Practices and Patient Care
- 75893 Long-term efficacy, complete scalp hair regrowth and normal body hair/nails in adolescents with severe alopecia areata (AA) receiving ritlecitinib up to 3 years in the ALLEGRO clinical trials
- Assessing Alopecia Areata Management in Poland: Challenges in Medical Practices and Patient Care
- Elevated serum heat shock protein-70 and interleukin-15: prognostic biomarkers correlating with clinical severity and diagnostic efficacy in active alopecia areata
- Predictive Factors of Response and Real‐World Experience of Baricitinib on Alopecia Areata: A Single Tertiary Center Study on a 72 Patients' Cohort
- Case Report: Omalizumab-associated hair loss: a case of eyebrow alopecia areata, literature review and FAERS database analysis
- Alopecia Areata and Systemic Lupus Erythematosus: Insights From a Nationwide Case–Control Study
- Efficacy of Oral Tofacitinib in Alopecia Areata, Alopecia Totalis, and Alopecia Universalis
- Alopecia Areata Is Associated with an Increased Risk for Prediabetes and Obesity: A Nationwide Case—Control Study
- Cryotherapy versus fractional carbon dioxide laser in patchy alopecia areata: a self-controlled comparative study
- Combination Treatment with Methotrexate for Severe Alopecia Areata
- Efficacy and Safety of Topical Tofacitinib for the Treatment of Alopecia Areata
- Features of sensitization in patients with alopecia areata, associated with atopic diseases
- Treatments for alopecia areata: a network meta-analysis
- Efficacy of Tofacitinib in the Treatment of Universal Alopecia Areata and Primary Sjögren Syndrome